QuidelOrtho (QDEL) CFO adds 3,370 shares in open‑market purchase

Rhea-AI Filing Summary

QuidelOrtho Corp’s Chief Financial Officer Joseph M. Busky reported an open‑market purchase of common stock. On February 13, 2026, a trust associated with him bought 3,370 shares at $23.6623 per share, bringing its indirect holdings to 10,290 shares and his direct holdings to 41,412 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Busky Joseph M.

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		P		3,370	A	$23.6623	10,290	I	By Trust
Common Stock								41,412	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Phillip S. Askim, attorney-in-fact for Joseph M. Busky	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did QuidelOrtho (QDEL) report for Joseph M. Busky?

QuidelOrtho reported that CFO Joseph M. Busky completed an open‑market purchase of 3,370 shares of common stock. The transaction occurred on February 13, 2026, and was executed at a price of $23.6623 per share through a trust.

At what price did the QuidelOrtho (QDEL) CFO buy shares on February 13, 2026?

The CFO’s trust purchased QuidelOrtho common stock at $23.6623 per share. This price applied to the entire 3,370‑share open‑market transaction reported for February 13, 2026, as disclosed in the Form 4 insider trading report.

How many QuidelOrtho (QDEL) shares does the CFO now hold indirectly and directly?

After the reported purchase, a trust associated with CFO Joseph M. Busky holds 10,290 shares indirectly. Separately, he is shown as directly owning 41,412 shares of QuidelOrtho common stock, according to the beneficial ownership information in the filing.

Was the QuidelOrtho (QDEL) CFO’s February 13, 2026 transaction a buy or a sell?

The reported transaction was a purchase, not a sale. The Form 4 uses transaction code P, indicating an open‑market or private purchase of 3,370 shares of QuidelOrtho common stock by a trust associated with the CFO.

How is the QuidelOrtho (QDEL) CFO’s ownership characterized in the Form 4 filing?

The filing shows indirect ownership of 10,290 shares held “By Trust” and direct ownership of 41,412 shares. Indirect ownership indicates the shares are held through a separate entity rather than in the executive’s personal name.

What role does Joseph M. Busky hold at QuidelOrtho (QDEL) in this Form 4?

Joseph M. Busky is identified as QuidelOrtho’s Chief Financial Officer in the insider report. The Form 4 notes his status as an officer of the company, rather than as a director or 10% owner, in the relationship section.